These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 11604987)
1. Combining transcatheter arterial chemoembolization with percutaneous ethanol injection therapy for small size hepatocellular carcinoma. Okano H; Shiraki K; Inoue H; Ito T; Yamanaka T; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Nakano T Int J Oncol; 2001 Nov; 19(5):909-12. PubMed ID: 11604987 [TBL] [Abstract][Full Text] [Related]
2. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma. Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925 [TBL] [Abstract][Full Text] [Related]
3. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate. Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976 [TBL] [Abstract][Full Text] [Related]
4. Treatment of hepatocellular carcinoma and the exacerbation of liver function. Okano H; Shiraki K; Inoue H; Deguchi M; Sugimoto K; Sakai T; Ohmori S; Murata K; Nakano T; Yamakado K; Takeda K Int J Oncol; 2001 Dec; 19(6):1279-82. PubMed ID: 11713600 [TBL] [Abstract][Full Text] [Related]
5. Follow-up study of combination treatment (TAE and PEIT) for unresectable hepatocellular carcinoma. Tateishi H; Kinuta M; Furukawa J; Takata N; Maruyama H; Oi H; Yayoi E; Okamura J Cancer Chemother Pharmacol; 1994; 33 Suppl():S119-23. PubMed ID: 8137470 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial. Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514 [TBL] [Abstract][Full Text] [Related]
7. [Studies on combination therapy with TAE and percutaneous ethanol injection therapy for unresectable hepatocellular carcinoma]. Tateishi H; Hasuike Y; Kinuta M; Furukawa J; Takata N; Maruyama H; Oi H; Yayoi E; Okamura J Gan To Kagaku Ryoho; 1993 Aug; 20(11):1492-4. PubMed ID: 8396903 [TBL] [Abstract][Full Text] [Related]
8. Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence. Horigome H; Nomura T; Saso K; Itoh M Am J Gastroenterol; 1999 Jul; 94(7):1914-7. PubMed ID: 10406259 [TBL] [Abstract][Full Text] [Related]
9. Appraisal of combination treatment for hepatocellular carcinoma: long-term follow-up and lipiodol-percutaneous ethanol injection therapy. Tateishi H; Oi H; Masuda N; Yano H; Matsui S; Kinuta M; Maruyama H; Yayoi E; Okamura J Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-81-S6-90. PubMed ID: 9151921 [TBL] [Abstract][Full Text] [Related]
10. Transcatheter arterial chemoembolization and percutaneous ethanol injection for Hepatocellular carcinoma: a retrospective review of the Veterans Affairs Caribbean Healthcare System. Narvaez-Lugo J; Cáceres WW; Toro DH; Pérez-González MR; Almodovar AA; Maldonado-Mercado AM; Salgado N; Rivera-Sanfeliz GM Cancer Control; 2008 Jan; 15(1):80-5. PubMed ID: 18094664 [TBL] [Abstract][Full Text] [Related]
11. Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series. Takano S; Watanabe Y; Ohishi H; Kono S; Nakamura M; Kubota N; Iwai S Eur J Surg Oncol; 2000 Feb; 26(1):67-72. PubMed ID: 10718183 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of combined therapy with chemoembolization and ethanol injection for advanced hepatocellular carcinoma. Yamamoto K; Masuzawa M; Kato M; Kurosawa K; Kaneko A; Ishida H; Imamura E; Park NJ; Shirai Y; Fujimoto K; Michida T; Hayashi N; Ikeda M Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-50-S6-55. PubMed ID: 9151917 [TBL] [Abstract][Full Text] [Related]
13. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study. Koda M; Murawaki Y; Mitsuda A; Oyama K; Okamoto K; Idobe Y; Suou T; Kawasaki H Cancer; 2001 Sep; 92(6):1516-24. PubMed ID: 11745230 [TBL] [Abstract][Full Text] [Related]
14. Combination therapy with transcatheter arterial embolization and percutaneous ethanol injection for advanced hepatocellular carcinoma. Koda M; Okamoto K; Miyoshi Y; Kato S; Murawaki Y; Horie Y; Suou T; Kawasaki H Hepatogastroenterology; 1994 Feb; 41(1):25-9. PubMed ID: 8175109 [TBL] [Abstract][Full Text] [Related]
15. Treatment of choice for unresectable small liver cancer: percutaneous ethanol injection therapy or transarterial chemoembolization therapy. Horiguchi Y; Sekoguchi B; Imai H; Suzuki T; Kubo H; Itoh H; Itoh M Cancer Chemother Pharmacol; 1994; 33 Suppl():S111-4. PubMed ID: 8137468 [TBL] [Abstract][Full Text] [Related]
16. Combination therapy of transcatheter chemoembolization and percutaneous ethanol injection therapy for unresectable hepatocellular carcinoma. Kato T; Saito Y; Niwa M; Ishiguro J; Ogoshi K Cancer Chemother Pharmacol; 1994; 33 Suppl():S115-8. PubMed ID: 8137469 [TBL] [Abstract][Full Text] [Related]
17. [Non-surgical (medical) treatment of hepatocellular carcinoma (HCC)]. Tanikawa K Gan To Kagaku Ryoho; 1989 Jan; 16(1):34-9. PubMed ID: 2536269 [TBL] [Abstract][Full Text] [Related]